Proteazom-aktivirani receptor 3 (PAR3), ili Receptoru koagulacionog faktora II (trombina) sličan 2, je protein kodiran F2RL2genom kod ljudi.
F2RL2 je član velike familije G-protein spregnutih receptora koji interaguju sa guanozin-nukleotid-vezujućim proteinima. PAR3 je takođe član familije proteazom aktiviranih receptora. On je aktiviran trombinom. Do aktivacije dolazi proteolitičkim odsecanjem njegovog ekstracelularnog amino terminusa. Novo-formirani amino terminus dejstvuje kao vezani ligand i aktivira receptor. F2RL2 je kofaktor za F2RL3 aktivaciju trombinom. On posreduje trombinom-podstaknutu fosfoinozitid hidrolizu. F2RL2 je izražen u nizu tkiva.[1]
Hollenberg MD, Compton SJ (2002). „International Union of Pharmacology. XXVIII. Proteinase-activated receptors.”. Pharmacol. Rev.54 (2): 203–17. DOI:10.1124/pr.54.2.203. PMID12037136.
Ishihara H, Connolly AJ, Zeng D, et al. (1997). „Protease-activated receptor 3 is a second thrombin receptor in humans.”. Nature386 (6624): 502–6. DOI:10.1038/386502a0. PMID9087410.
Schmidt VA, Nierman WC, Maglott DR, et al. (1998). „The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets.”. J. Biol. Chem.273 (24): 15061–8. DOI:10.1074/jbc.273.24.15061. PMID9614115.
Kahn ML, Zheng YW, Huang W, et al. (1998). „A dual thrombin receptor system for platelet activation.”. Nature394 (6694): 690–4. DOI:10.1038/29325. PMID9716134.
Kahn ML, Hammes SR, Botka C, Coughlin SR (1998). „Gene and locus structure and chromosomal localization of the protease-activated receptor gene family.”. J. Biol. Chem.273 (36): 23290–6. DOI:10.1074/jbc.273.36.23290. PMID9722561.
Hauck RW, Schulz C, Schömig A, et al. (1999). „alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors.”. Am. J. Physiol.277 (1 Pt 1): L22–9. PMID10409227.
Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. (2000). „PAR3 is a cofactor for PAR4 activation by thrombin.”. Nature404 (6778): 609–13. DOI:10.1038/35007085. PMID10766244.
O'Brien PJ, Prevost N, Molino M, et al. (2000). „Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1.”. J. Biol. Chem.275 (18): 13502–9. DOI:10.1074/jbc.275.18.13502. PMID10788464.
Cumashi A, Ansuini H, Celli N, et al. (2001). „Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.”. Thromb. Haemost.85 (3): 533–8. PMID11307827.
Sambrano GR, Weiss EJ, Zheng YW, et al. (2001). „Role of thrombin signalling in platelets in haemostasis and thrombosis.”. Nature413 (6851): 74–8. DOI:10.1038/35092573. PMID11544528.
Miike S, McWilliam AS, Kita H (2002). „Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2.”. J. Immunol.167 (11): 6615–22. PMID11714832.
Uehara A, Sugawara S, Muramoto K, Takada H (2002). „Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2.”. J. Immunol.169 (8): 4594–603. PMID12370398.
Owen WG (2003). „PAR-3 is a low-affinity substrate, high affinity effector of thrombin.”. Biochem. Biophys. Res. Commun.305 (1): 166–8. DOI:10.1016/S0006-291X(03)00732-0. PMID12732212.
„Protease-Activated Receptors: PAR3”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-04.